APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Afatinib Maleate Tablets

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Afatinib Maleate Tablets Market Outlook and Growth Opportunities 2026

Report ID 173961220429 December 2025198 pages

Choose your research edition.

Industry ResearchAfatinib Maleate Tablets Industry Research Report 2026119 pages · $2,950 USDIndustry Growth & TrendsGlobal Afatinib Maleate Tablets Industry Growth and Trends Forecast to 203286 pages · $3,450 USDMarket StructureGlobal Afatinib Maleate Tablets Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032182 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Afatinib Maleate Tablets Market Outlook and Growth Opportunities 2026198 pages · $4,250 USDMarket Analysis & ForecastGlobal Afatinib Maleate Tablets Market Analysis and Forecast 2026-2032194 pages · $4,950 USD

Market perspective

The global Afatinib Maleate Tablets market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Afatinib Maleate Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Afatinib Maleate Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Afatinib Maleate Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Afatinib Maleate Tablets market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Afatinib Maleate Tablets market include Yangtze River Pharm, Qingfeng Medicine Group, Qilu Pharmaceutical, Beacon Pharmaceuticals, Kelun－Kazpharm, Hansoh Pharmaceuticak, Chia Tai-Tianqing and Boehringer Ingelheim International GmbH, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global Afatinib Maleate Tablets market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Afatinib Maleate Tablets and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Afatinib Maleate Tablets revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Afatinib Maleate Tablets market.

Afatinib Maleate Tablets Segment by Company

Yangtze River Pharm

Qingfeng Medicine Group

Qilu Pharmaceutical

Beacon Pharmaceuticals

Kelun－Kazpharm

Hansoh Pharmaceuticak

Chia Tai-Tianqing

Boehringer Ingelheim International GmbH

Afatinib Maleate Tablets Segment by Type

50mg

40mg

30mg

20mg

Afatinib Maleate Tablets Segment by Application

Hospital

Clinic

Others

Afatinib Maleate Tablets Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Afatinib Maleate Tablets status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Afatinib Maleate Tablets key companies, revenue, market share, and recent developments.

3. To split the Afatinib Maleate Tablets breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Afatinib Maleate Tablets market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Afatinib Maleate Tablets significant trends, drivers, influence factors in global and regions.

6. To analyze Afatinib Maleate Tablets competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Afatinib Maleate Tablets market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Afatinib Maleate Tablets and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Afatinib Maleate Tablets.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Afatinib Maleate Tablets industry.

Chapter 3: Detailed analysis of Afatinib Maleate Tablets company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Afatinib Maleate Tablets in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Afatinib Maleate Tablets in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Afatinib Maleate Tablets Industry Trends Table 2. Afatinib Maleate Tablets Industry Drivers Table 3. Afatinib Maleate Tablets Industry Opportunities and Challenges Table 4. Afatinib Maleate Tablets Industry Restraints Table 5. Global Afatinib Maleate Tablets Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Afatinib Maleate Tablets Revenue Share by Company (2021-2026) Table 7. Global Afatinib Maleate Tablets Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Afatinib Maleate Tablets Key Company Manufacturing Base & Headquarters Table 9. Global Afatinib Maleate Tablets Company, Product Type & Application Table 10. Global Afatinib Maleate Tablets Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Afatinib Maleate Tablets by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of 50mg Table 15. Significant Companies of 40mg Table 16. Significant Companies of 30mg Table 17. Significant Companies of 20mg Table 18. Global Afatinib Maleate Tablets Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 19. Global Afatinib Maleate Tablets Sales Value by Type (2021-2026) & (US$ Million) Table 20. Global Afatinib Maleate Tablets Sales Value by Type (2027-2032) & (US$ Million) Table 21. Global Afatinib Maleate Tablets Sales Value Share by Type (2021-2026) Table 22. Global Afatinib Maleate Tablets Sales Value Share by Type (2027-2032) Table 23. Significant Companies of Hospital Table 24. Significant Companies of Clinic Table 25. Significant Companies of Others Table 26. Global Afatinib Maleate Tablets Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 27. Global Afatinib Maleate Tablets Sales Value by Application (2021-2026) & (US$ Million) Table 28. Global Afatinib Maleate Tablets Sales Value by Application (2027-2032) & (US$ Million) Table 29. Global Afatinib Maleate Tablets Sales Value Share by Application (2021-2026) Table 30. Global Afatinib Maleate Tablets Sales Value Share by Application (2027-2032) Table 31. Global Afatinib Maleate Tablets Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 32. Global Afatinib Maleate Tablets Sales Value by Region (2021-2026) & (US$ Million) Table 33. Global Afatinib Maleate Tablets Sales Value Share by Region (2021-2026) Table 34. Global Afatinib Maleate Tablets Sales Value by Region (2027-2032) & (US$ Million) Table 35. Global Afatinib Maleate Tablets Sales Value Share by Region (2027-2032) Table 36. Global Afatinib Maleate Tablets Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 37. Global Afatinib Maleate Tablets Sales Value by Country (2021-2026) & (US$ Million) Table 38. Global Afatinib Maleate Tablets Sales Value Market Share by Country (2021-2026) Table 39. Global Afatinib Maleate Tablets Sales Value by Country (2027-2032) & (US$ Million) Table 40. Global Afatinib Maleate Tablets Sales Value Market Share by Country (2027-2032) Table 41. Yangtze River Pharm Company Information Table 42. Yangtze River Pharm Business Overview Table 43. Yangtze River Pharm Afatinib Maleate Tablets Revenue (US$ Million) and Gross Margin (2021-2026) Table 44. Yangtze River Pharm Afatinib Maleate Tablets Product Portfolio Table 45. Yangtze River Pharm Recent Development Table 46. Qingfeng Medicine Group Company Information Table 47. Qingfeng Medicine Group Business Overview Table 48. Qingfeng Medicine Group Afatinib Maleate Tablets Revenue (US$ Million) and Gross Margin (2021-2026) Table 49. Qingfeng Medicine Group Afatinib Maleate Tablets Product Portfolio Table 50. Qingfeng Medicine Group Recent Development Table 51. Qilu Pharmaceutical Company Information Table 52. Qilu Pharmaceutical Business Overview Table 53. Qilu Pharmaceutical Afatinib Maleate Tablets Revenue (US$ Million) and Gross Margin (2021-2026) Table 54. Qilu Pharmaceutical Afatinib Maleate Tablets Product Portfolio Table 55. Qilu Pharmaceutical Recent Development Table 56. Beacon Pharmaceuticals Company Information Table 57. Beacon Pharmaceuticals Business Overview Table 58. Beacon Pharmaceuticals Afatinib Maleate Tablets Revenue (US$ Million) and Gross Margin (2021-2026) Table 59. Beacon Pharmaceuticals Afatinib Maleate Tablets Product Portfolio Table 60. Beacon Pharmaceuticals Recent Development Table 61. Kelun－Kazpharm Company Information Table 62. Kelun－Kazpharm Business Overview Table 63. Kelun－Kazpharm Afatinib Maleate Tablets Revenue (US$ Million) and Gross Margin (2021-2026) Table 64. Kelun－Kazpharm Afatinib Maleate Tablets Product Portfolio Table 65. Kelun－Kazpharm Recent Development Table 66. Hansoh Pharmaceuticak Company Information Table 67. Hansoh Pharmaceuticak Business Overview Table 68. Hansoh Pharmaceuticak Afatinib Maleate Tablets Revenue (US$ Million) and Gross Margin (2021-2026) Table 69. Hansoh Pharmaceuticak Afatinib Maleate Tablets Product Portfolio Table 70. Hansoh Pharmaceuticak Recent Development Table 71. Chia Tai-Tianqing Company Information Table 72. Chia Tai-Tianqing Business Overview Table 73. Chia Tai-Tianqing Afatinib Maleate Tablets Revenue (US$ Million) and Gross Margin (2021-2026) Table 74. Chia Tai-Tianqing Afatinib Maleate Tablets Product Portfolio Table 75. Chia Tai-Tianqing Recent Development Table 76. Boehringer Ingelheim International GmbH Company Information Table 77. Boehringer Ingelheim International GmbH Business Overview Table 78. Boehringer Ingelheim International GmbH Afatinib Maleate Tablets Revenue (US$ Million) and Gross Margin (2021-2026) Table 79. Boehringer Ingelheim International GmbH Afatinib Maleate Tablets Product Portfolio Table 80. Boehringer Ingelheim International GmbH Recent Development Table 81. Research Programs/Design for This Report Table 82. Authors List of This Report Table 83. Secondary Sources Table 84. Primary Sources List of Figures Figure 1. Afatinib Maleate Tablets Product Image Figure 2. Global Afatinib Maleate Tablets Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Afatinib Maleate Tablets Market Size (2021-2032) & (US$ Million) Figure 4. Global Afatinib Maleate Tablets Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. 50mg Image Figure 8. 40mg Image Figure 9. 30mg Image Figure 10. 20mg Image Figure 11. Global Afatinib Maleate Tablets Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 12. Global Afatinib Maleate Tablets Sales Value Share 2021 VS 2025 VS 2032 Figure 13. Global Afatinib Maleate Tablets Sales Value Share by Type (2021-2032) Figure 14. Hospital Image Figure 15. Clinic Image Figure 16. Others Image Figure 17. Global Afatinib Maleate Tablets Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 18. Global Afatinib Maleate Tablets Sales Value Share 2021 VS 2025 VS 2032 Figure 19. Global Afatinib Maleate Tablets Sales Value Share by Application (2021-2032) Figure 20. Global Afatinib Maleate Tablets Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 21. Global Afatinib Maleate Tablets Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 22. North America Afatinib Maleate Tablets Sales Value (2021-2032) & (US$ Million) Figure 23. North America Afatinib Maleate Tablets Sales Value Share by Country (%), 2025 VS 2032 Figure 24. Europe Afatinib Maleate Tablets Sales Value (2021-2032) & (US$ Million) Figure 25. Europe Afatinib Maleate Tablets Sales Value Share by Country (%), 2025 VS 2032 Figure 26. Asia-Pacific Afatinib Maleate Tablets Sales Value (2021-2032) & (US$ Million) Figure 27. Asia-Pacific Afatinib Maleate Tablets Sales Value Share by Country (%), 2025 VS 2032 Figure 28. South America Afatinib Maleate Tablets Sales Value (2021-2032) & (US$ Million) Figure 29. South America Afatinib Maleate Tablets Sales Value Share by Country (%), 2025 VS 2032 Figure 30. Middle East & Africa Afatinib Maleate Tablets Sales Value (2021-2032) & (US$ Million) Figure 31. Middle East & Africa Afatinib Maleate Tablets Sales Value Share by Country (%), 2025 VS 2032 Figure 32. USA Afatinib Maleate Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 33. USA Afatinib Maleate Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 34. USA Afatinib Maleate Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 35. Canada Afatinib Maleate Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 36. Canada Afatinib Maleate Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 37. Canada Afatinib Maleate Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 38. Mexico Afatinib Maleate Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 39. Mexico Afatinib Maleate Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 40. Mexico Afatinib Maleate Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 41. Germany Afatinib Maleate Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 42. Germany Afatinib Maleate Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 43. Germany Afatinib Maleate Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 44. France Afatinib Maleate Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 45. France Afatinib Maleate Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 46. France Afatinib Maleate Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 47. U.K. Afatinib Maleate Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 48. U.K. Afatinib Maleate Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 49. U.K. Afatinib Maleate Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 50. Italy Afatinib Maleate Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 51. Italy Afatinib Maleate Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 52. Italy Afatinib Maleate Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 53. Spain Afatinib Maleate Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 54. Spain Afatinib Maleate Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 55. Spain Afatinib Maleate Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 56. Russia Afatinib Maleate Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 57. Russia Afatinib Maleate Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 58. Russia Afatinib Maleate Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 59. Netherlands Afatinib Maleate Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 60. Netherlands Afatinib Maleate Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 61. Netherlands Afatinib Maleate Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 62. Nordic Countries Afatinib Maleate Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 63. Nordic Countries Afatinib Maleate Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 64. Nordic Countries Afatinib Maleate Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 65. China Afatinib Maleate Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 66. China Afatinib Maleate Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 67. China Afatinib Maleate Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 68. Japan Afatinib Maleate Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 69. Japan Afatinib Maleate Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 70. Japan Afatinib Maleate Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 71. South Korea Afatinib Maleate Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 72. South Korea Afatinib Maleate Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 73. South Korea Afatinib Maleate Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 74. India Afatinib Maleate Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 75. India Afatinib Maleate Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 76. India Afatinib Maleate Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 77. Australia Afatinib Maleate Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 78. Australia Afatinib Maleate Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 79. Australia Afatinib Maleate Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 80. Southeast Asia Afatinib Maleate Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 81. Southeast Asia Afatinib Maleate Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 82. Southeast Asia Afatinib Maleate Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 83. Brazil Afatinib Maleate Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 84. Brazil Afatinib Maleate Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 85. Brazil Afatinib Maleate Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 86. Argentina Afatinib Maleate Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 87. Argentina Afatinib Maleate Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 88. Argentina Afatinib Maleate Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 89. Chile Afatinib Maleate Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 90. Chile Afatinib Maleate Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 91. Chile Afatinib Maleate Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 92. Colombia Afatinib Maleate Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 93. Colombia Afatinib Maleate Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 94. Colombia Afatinib Maleate Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 95. Peru Afatinib Maleate Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 96. Peru Afatinib Maleate Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 97. Peru Afatinib Maleate Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 98. Saudi Arabia Afatinib Maleate Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 99. Saudi Arabia Afatinib Maleate Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 100. Saudi Arabia Afatinib Maleate Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 101. Israel Afatinib Maleate Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 102. Israel Afatinib Maleate Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 103. Israel Afatinib Maleate Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 104. UAE Afatinib Maleate Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 105. UAE Afatinib Maleate Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 106. UAE Afatinib Maleate Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 107. Turkey Afatinib Maleate Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 108. Turkey Afatinib Maleate Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 109. Turkey Afatinib Maleate Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 110. Iran Afatinib Maleate Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 111. Iran Afatinib Maleate Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 112. Iran Afatinib Maleate Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 113. Egypt Afatinib Maleate Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 114. Egypt Afatinib Maleate Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 115. Egypt Afatinib Maleate Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 116. Years Considered Figure 117. Research Process Figure 118. Key Executives Interviewed

Scope & coverage.

Types
  • 50mg
  • 40mg
  • 30mg
  • 20mg
Applications
  • Hospital
  • Clinic
  • Others
Companies covered
  • Yangtze River Pharm
  • Qingfeng Medicine Group
  • Qilu Pharmaceutical
  • Beacon Pharmaceuticals
  • Kelun－Kazpharm
  • Hansoh Pharmaceuticak
  • Chia Tai-Tianqing
  • Boehringer Ingelheim International GmbH

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Afatinib Maleate Tablets Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Afatinib Maleate Tablets Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Afatinib Maleate Tablets Market Dynamics
  1. 2.1 Afatinib Maleate Tablets Industry Trends
  2. 2.2 Afatinib Maleate Tablets Industry Drivers
  3. 2.3 Afatinib Maleate Tablets Industry Opportunities and Challenges
  4. 2.4 Afatinib Maleate Tablets Industry Restraints
3 Afatinib Maleate Tablets Market by Company
  1. 3.1 Global Afatinib Maleate Tablets Company Revenue Ranking in 2025
  2. 3.2 Global Afatinib Maleate Tablets Revenue by Company (2021-2026)
  3. 3.3 Global Afatinib Maleate Tablets Company Ranking (2024-2026)
  4. 3.4 Global Afatinib Maleate Tablets Company Manufacturing Base and Headquarters
  5. 3.5 Global Afatinib Maleate Tablets Company Product Type and Application
  6. 3.6 Global Afatinib Maleate Tablets Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Afatinib Maleate Tablets Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Afatinib Maleate Tablets Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Afatinib Maleate Tablets Market by Type
  1. 4.1 Afatinib Maleate Tablets Type Introduction
  2. 4.1.1 50mg
  3. 4.1.2 40mg
  4. 4.1.3 30mg
  5. 4.1.4 20mg
  6. 4.2 Global Afatinib Maleate Tablets Sales Value by Type
  7. 4.2.1 Global Afatinib Maleate Tablets Sales Value by Type (2021 VS 2025 VS 2032)
  8. 4.2.2 Global Afatinib Maleate Tablets Sales Value by Type (2021-2032)
  9. 4.2.3 Global Afatinib Maleate Tablets Sales Value Share by Type (2021-2032)
5 Afatinib Maleate Tablets Market by Application
  1. 5.1 Afatinib Maleate Tablets Application Introduction
  2. 5.1.1 Hospital
  3. 5.1.2 Clinic
  4. 5.1.3 Others
  5. 5.2 Global Afatinib Maleate Tablets Sales Value by Application
  6. 5.2.1 Global Afatinib Maleate Tablets Sales Value by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Afatinib Maleate Tablets Sales Value by Application (2021-2032)
  8. 5.2.3 Global Afatinib Maleate Tablets Sales Value Share by Application (2021-2032)
6 Afatinib Maleate Tablets Regional Value Analysis
  1. 6.1 Global Afatinib Maleate Tablets Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Afatinib Maleate Tablets Sales Value by Region (2021-2032)
  3. 6.2.1 Global Afatinib Maleate Tablets Sales Value by Region: 2021-2026
  4. 6.2.2 Global Afatinib Maleate Tablets Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Afatinib Maleate Tablets Sales Value (2021-2032)
  7. 6.3.2 North America Afatinib Maleate Tablets Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Afatinib Maleate Tablets Sales Value (2021-2032)
  10. 6.4.2 Europe Afatinib Maleate Tablets Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Afatinib Maleate Tablets Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Afatinib Maleate Tablets Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Afatinib Maleate Tablets Sales Value (2021-2032)
  16. 6.6.2 South America Afatinib Maleate Tablets Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Afatinib Maleate Tablets Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Afatinib Maleate Tablets Sales Value Share by Country, 2025 VS 2032
7 Afatinib Maleate Tablets Country-level Value Analysis
  1. 7.1 Global Afatinib Maleate Tablets Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Afatinib Maleate Tablets Sales Value by Country (2021-2032)
  3. 7.2.1 Global Afatinib Maleate Tablets Sales Value by Country (2021-2026)
  4. 7.2.2 Global Afatinib Maleate Tablets Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Afatinib Maleate Tablets Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Afatinib Maleate Tablets Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Afatinib Maleate Tablets Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Afatinib Maleate Tablets Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Afatinib Maleate Tablets Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Afatinib Maleate Tablets Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Afatinib Maleate Tablets Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Afatinib Maleate Tablets Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Afatinib Maleate Tablets Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Afatinib Maleate Tablets Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Afatinib Maleate Tablets Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Afatinib Maleate Tablets Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Afatinib Maleate Tablets Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Afatinib Maleate Tablets Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Afatinib Maleate Tablets Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Afatinib Maleate Tablets Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Afatinib Maleate Tablets Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Afatinib Maleate Tablets Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Afatinib Maleate Tablets Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Afatinib Maleate Tablets Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Afatinib Maleate Tablets Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Afatinib Maleate Tablets Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Afatinib Maleate Tablets Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Afatinib Maleate Tablets Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Afatinib Maleate Tablets Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Afatinib Maleate Tablets Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Afatinib Maleate Tablets Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Afatinib Maleate Tablets Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Afatinib Maleate Tablets Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Afatinib Maleate Tablets Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Afatinib Maleate Tablets Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Afatinib Maleate Tablets Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Afatinib Maleate Tablets Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Afatinib Maleate Tablets Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Afatinib Maleate Tablets Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Afatinib Maleate Tablets Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Afatinib Maleate Tablets Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Afatinib Maleate Tablets Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Afatinib Maleate Tablets Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Afatinib Maleate Tablets Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Afatinib Maleate Tablets Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Afatinib Maleate Tablets Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Afatinib Maleate Tablets Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Afatinib Maleate Tablets Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Afatinib Maleate Tablets Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Afatinib Maleate Tablets Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Afatinib Maleate Tablets Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Afatinib Maleate Tablets Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Afatinib Maleate Tablets Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Afatinib Maleate Tablets Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Afatinib Maleate Tablets Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Afatinib Maleate Tablets Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Afatinib Maleate Tablets Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Afatinib Maleate Tablets Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Afatinib Maleate Tablets Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Afatinib Maleate Tablets Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Afatinib Maleate Tablets Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Afatinib Maleate Tablets Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Afatinib Maleate Tablets Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Afatinib Maleate Tablets Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Afatinib Maleate Tablets Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Afatinib Maleate Tablets Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Afatinib Maleate Tablets Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Afatinib Maleate Tablets Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Afatinib Maleate Tablets Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Afatinib Maleate Tablets Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Afatinib Maleate Tablets Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Afatinib Maleate Tablets Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Afatinib Maleate Tablets Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Afatinib Maleate Tablets Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Afatinib Maleate Tablets Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Afatinib Maleate Tablets Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Afatinib Maleate Tablets Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Afatinib Maleate Tablets Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Afatinib Maleate Tablets Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Afatinib Maleate Tablets Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Afatinib Maleate Tablets Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Afatinib Maleate Tablets Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Afatinib Maleate Tablets Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Afatinib Maleate Tablets Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Afatinib Maleate Tablets Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Afatinib Maleate Tablets Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Afatinib Maleate Tablets Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Afatinib Maleate Tablets Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Yangtze River Pharm
  2. 8.1.1 Yangtze River Pharm Company Information
  3. 8.1.2 Yangtze River Pharm Business Overview
  4. 8.1.3 Yangtze River Pharm Afatinib Maleate Tablets Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Yangtze River Pharm Afatinib Maleate Tablets Product Portfolio
  6. 8.1.5 Yangtze River Pharm Recent Developments
  7. 8.2 Qingfeng Medicine Group
  8. 8.2.1 Qingfeng Medicine Group Company Information
  9. 8.2.2 Qingfeng Medicine Group Business Overview
  10. 8.2.3 Qingfeng Medicine Group Afatinib Maleate Tablets Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Qingfeng Medicine Group Afatinib Maleate Tablets Product Portfolio
  12. 8.2.5 Qingfeng Medicine Group Recent Developments
  13. 8.3 Qilu Pharmaceutical
  14. 8.3.1 Qilu Pharmaceutical Company Information
  15. 8.3.2 Qilu Pharmaceutical Business Overview
  16. 8.3.3 Qilu Pharmaceutical Afatinib Maleate Tablets Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Qilu Pharmaceutical Afatinib Maleate Tablets Product Portfolio
  18. 8.3.5 Qilu Pharmaceutical Recent Developments
  19. 8.4 Beacon Pharmaceuticals
  20. 8.4.1 Beacon Pharmaceuticals Company Information
  21. 8.4.2 Beacon Pharmaceuticals Business Overview
  22. 8.4.3 Beacon Pharmaceuticals Afatinib Maleate Tablets Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Beacon Pharmaceuticals Afatinib Maleate Tablets Product Portfolio
  24. 8.4.5 Beacon Pharmaceuticals Recent Developments
  25. 8.5 Kelun－Kazpharm
  26. 8.5.1 Kelun－Kazpharm Company Information
  27. 8.5.2 Kelun－Kazpharm Business Overview
  28. 8.5.3 Kelun－Kazpharm Afatinib Maleate Tablets Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Kelun－Kazpharm Afatinib Maleate Tablets Product Portfolio
  30. 8.5.5 Kelun－Kazpharm Recent Developments
  31. 8.6 Hansoh Pharmaceuticak
  32. 8.6.1 Hansoh Pharmaceuticak Company Information
  33. 8.6.2 Hansoh Pharmaceuticak Business Overview
  34. 8.6.3 Hansoh Pharmaceuticak Afatinib Maleate Tablets Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Hansoh Pharmaceuticak Afatinib Maleate Tablets Product Portfolio
  36. 8.6.5 Hansoh Pharmaceuticak Recent Developments
  37. 8.7 Chia Tai-Tianqing
  38. 8.7.1 Chia Tai-Tianqing Company Information
  39. 8.7.2 Chia Tai-Tianqing Business Overview
  40. 8.7.3 Chia Tai-Tianqing Afatinib Maleate Tablets Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Chia Tai-Tianqing Afatinib Maleate Tablets Product Portfolio
  42. 8.7.5 Chia Tai-Tianqing Recent Developments
  43. 8.8 Boehringer Ingelheim International GmbH
  44. 8.8.1 Boehringer Ingelheim International GmbH Company Information
  45. 8.8.2 Boehringer Ingelheim International GmbH Business Overview
  46. 8.8.3 Boehringer Ingelheim International GmbH Afatinib Maleate Tablets Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Boehringer Ingelheim International GmbH Afatinib Maleate Tablets Product Portfolio
  48. 8.8.5 Boehringer Ingelheim International GmbH Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst